Catalog No.
Product Name
Application
Product Information
Citations
-
Drug Impurity
Leflunomide impurity 8 is identified as 5-Methyl-N-(p-tolyl)isoxazole-4-carboxamide and serves as a drug impurity. This compound may be utilized in pharmacological studies and analytical chemistry to assess the purity and quality of leflunomide formulations. Its presence can impact the evaluation of drug safety and efficacy, making it a significant marker in drug development and quality control processes. -
Drug Impurity
Glipizide impurity 2, also known as Glipizide impurity A, is a known impurity associated with the antidiabetic agent Glipizide. This compound is essential for analytical development and quality control in pharmaceutical research, helping to ensure the purity and safety of Glipizide formulations. Its identification and quantification are critical in compliance with regulatory standards for drug manufacturing. -
Drug Impurity
Paliperidone impurity 11 is a defluorinated derivative of Paliperidone, serving as a key impurity in drug synthesis and quality control. This compound is utilized in the assessment of Paliperidone formulations to ensure compliance with pharmaceutical standards and regulations. Its characterization is essential in understanding the stability, efficacy, and safety of the final pharmaceutical product. -
Drug Impurity
Sildenafil Impurity 3 is a chemical byproduct associated with the phosphodiesterase type 5 (PDE5) inhibitor sildenafil. This impurity is crucial for quality control and safety assessments in pharmaceutical formulations of sildenafil. It serves as a reference standard in analytical chemistry for identifying and quantifying impurities during the development and testing of PDE5 inhibitors, ensuring regulatory compliance and product integrity. -
Drug Impurity
Clindamycin phosphate impurity 8 is a known impurity of clindamycin phosphate, affecting the overall quality and efficacy of formulations containing this antibiotic. Its presence can influence pharmacokinetics and pharmacodynamics, making it important in stability studies and quality control assessments. This compound is primarily utilized in the analysis of clindamycin phosphate formulations in pharmaceutical research and development. -
Drug Impurity
Azilsartan Impurity 30, also known as Azilsartan-13, is a chemical impurity associated with the antihypertensive agent Azilsartan. This compound is utilized primarily for analytical and quality control purposes in pharmaceutical research. It provides insight into the purity of Azilsartan and assists in the evaluation of formulation stability and efficacy. -
Drug Impurity
Testosterone impurity 6 is a notable impurity associated with Testosterone. This compound is critical for analytical studies in pharmaceutical research, particularly in the evaluation of drug purity and stability. Its presence can impact pharmacokinetic profiles and may influence the overall safety and efficacy of testosterone-derived therapies. Testing for this impurity is essential for ensuring compliance with regulatory standards in the development of hormone-related medications. -
Drug Intermediate Control
3-Aminobenzothioamide is a synthetic intermediate primarily utilized in pharmaceutical synthesis. This compound serves as a valuable building block in the development of various therapeutic agents. Its ability to participate in diverse chemical reactions makes it integral for generating complex molecules in drug discovery and development processes. -
Drug Impurity
Chlorthalidone impurity 4 is a known impurity associated with the thiazide diuretic chlorthalidone. It plays a significant role in pharmaceutical analysis, particularly in the assessment of drug quality and purity. This compound is utilized in regulatory settings to ensure compliance with guidelines for impurity levels in therapeutic formulations. Its characterization aids in understanding the stability and safety profiles of chlorthalidone-based medications. -
Drug Intermediate
(1R,3R)-3-Hydroxycyclopentane carboxylic acid methyl ester is a synthetic intermediate that facilitates pharmaceutical synthesis. This compound serves as a building block in the development of various bioactive molecules and is essential for exploring structure-activity relationships in medicinal chemistry. Its unique structural features make it valuable for generating novel therapeutic agents. -
Drug Impurity
Everolimus impurity 16 is a known impurity of the mTOR inhibitor Everolimus. It is essential for analytical and quality control studies, particularly in the evaluation of Everolimus formulations. This compound can be used to assess the purity and stability of pharmaceutical preparations, providing crucial data for drug development and regulatory compliance. -
Drug Impurity
Abacavir impurity 9 is a drug impurity associated with Abacavir, an antiretroviral medication used in the treatment of HIV. This compound is important for quality control and analytical studies in pharmaceutical research, assisting in understanding the stability and degradation pathways of Abacavir. Its characterization is crucial for ensuring the safety and efficacy of formulations containing Abacavir. -
Drug Impurity
Allopurinol impurity 5 is a chemical impurity associated with the synthesis of Allopurinol, which primarily targets xanthine oxidase. This impurity can be utilized in pharmacokinetic and toxicological studies to assess the purity of Allopurinol formulations. Its analysis is critical for ensuring the quality and safety of pharmaceutical products containing Allopurinol. -
Drug Impurity
Buspirone Impurity 10 is a identified impurity of the anxiolytic compound buspirone, primarily associated with its synthesis and analytical evaluation. This compound serves as a reference standard for the characterization and quantification of impurities in pharmaceutical formulations. It is valuable for quality control and regulatory compliance in drug development and production processes. -
Drug Impurity
Trelagliptin impurity 2 is an impurity associated with Trelagliptin, a DPP-4 inhibitor. This compound serves as an essential reference for the identification and quantification of potential impurities in pharmaceutical formulations. It is particularly relevant for analytical studies focused on the characterization of drug purity and stability in drug development processes. -
Drug Impurity
Oxcarbazepine impurity 1 is a known impurity associated with the anticonvulsant drug Oxcarbazepine. This compound is utilized primarily in drug development and quality control settings, where assessing the presence and concentration of impurities is critical for ensuring compliance with regulatory standards. Research applications include analytical method development and safety evaluation of pharmaceutical formulations containing Oxcarbazepine. -
Drug Intermediate
4-Methylhexahydroisobenzofuran-1,3-dione is a versatile chemical intermediate primarily utilized in the synthesis of various solvents, resins, and adhesives. Its structure allows it to participate in a range of chemical reactions, making it valuable in industrial applications. This compound serves as a key building block for the development of specialized polymeric materials and other functional products in chemical research. -
Drug Impurity
Doxycycline impurity 2 is a structural impurity associated with the antibiotic Doxycycline. Its presence may affect the purity profile of Doxycycline in pharmaceutical formulations. This compound serves as a reference standard for analytical purposes in drug development and quality control, ensuring that the levels of impurities are monitored in accordance with regulatory guidelines. -
Drug Impurity
Rosuvastatin impurity 25 calcium is a chemical impurity associated with Rosuvastatin calcium, a widely used statin for lowering cholesterol levels. It serves a critical role in analytical research, particularly in the evaluation of drug purity and safety. This impurity is essential for quality control and regulatory compliance in pharmaceutical development. -
Drug Impurity
Rosuvastatin impurity 11 is identified as a chemical impurity associated with the pharmaceutical agent Rosuvastatin. This compound serves as a critical reference standard in the assessment of drug purity and quality control during pharmaceutical development. It is utilized in analytical method validation and regulatory submissions, ensuring compliance with safety and efficacy standards in the production of statin-based therapies. -
Drug Impurity
Candesartan impurity 32 is characterized as a drug impurity associated with candesartan synthesis. This compound is important for the quality control and analytical assessments of candesartan formulations. Its identification and quantification are crucial for ensuring the purity and safety of pharmaceutical products containing candesartan. -
Drug Impurity
Trazodone Impurity 5 Hydrochloride is a known impurity associated with the antidepressant Trazodone Hydrochloride. This compound is primarily utilized in pharmaceutical development and quality control studies to assess drug purity and compliance with regulatory standards. Its characterization aids in understanding the stability and safety profile of Trazodone formulations. -
Drug Impurity
Itraconazole impurity 7, also known as Itraconazole impurity B, is a known impurity of the antifungal agent Itraconazole. It serves as a critical substance for the evaluation of drug purity, safety, and efficacy in pharmaceutical research. This compound is utilized in analytical chemistry and quality control processes to ensure the integrity of Itraconazole formulations. -
Drug Impurity
Levomedetomidine is a drug impurity associated with the anesthetic agent dexmedetomidine. It serves as a valuable reference compound in the analysis and characterization of pharmaceutical formulations. Its presence may influence the pharmacological properties and safety profile of dexmedetomidine, making it important for quality control and regulatory compliance in drug development studies. Researchers can utilize levomedetomidine to better understand the implications of drug impurities in pharmacokinetics and efficacy. -
Drug Impurity
Telmisartan impurity 3 is a recognized impurity of the antihypertensive agent telmisartan. Its presence can be relevant in pharmaceutical development and quality control processes. This compound serves as a useful reference standard for analytical methods and ensures the integrity and safety of telmisartan formulations in research applications. -
Drug Impurity
Dexamethasone acetate impurity 1 is a known impurity of Dexamethasone acetate, a synthetic corticosteroid. This compound is primarily utilized in quality control and analytical chemistry to assess the purity of Dexamethasone acetate formulations. It serves as a key reference standard for studies on drug formulation and stability, ensuring compliance with regulatory standards in pharmaceutical research. -
Drug Impurity
Raloxifene impurity 4 is a chemical impurity associated with Raloxifene, a selective estrogen receptor modulator (SERM). It serves as a critical reference standard in the analysis of drug formulation and quality control processes. Researchers can utilize this impurity to assess the purity of Raloxifene in pharmaceutical preparations, ensuring compliance with regulatory standards and enhancing the safety and efficacy of therapeutic applications. -
Drug Impurity
Candesartan impurity 24 is a chemical impurity associated with Candesartan, an angiotensin II receptor antagonist. This compound is primarily utilized in research for the assessment of drug purity and the development of analytical methods for quality control. Its presence in formulations can significantly impact pharmacological efficacy and safety profiles, making it essential for studies focused on drug formulations and stability. -
Drug Impurity
Bupropion impurity 2 is a secondary metabolite associated with Bupropion, a widely used antidepressant and smoking cessation aid. This impurity may influence pharmacokinetic properties and can be utilized in studies assessing the quality and safety of pharmaceutical formulations. Its assessment is crucial for understanding the overall therapeutic profile of Bupropion and ensuring compliance with regulatory standards in drug development. -
Drug Impurity
Sertraline impurity 10 is a chemical impurity associated with the selective serotonin reuptake inhibitor (SSRI) sertraline. This impurity is relevant for analytical and quality control studies in pharmaceutical research, particularly in the assessment of sertraline's purity and stability. Its presence may impact the safety and efficacy profile of sertraline, making it essential for compliance with regulatory standards in drug development. -
Drug Impurity
Tranexamic acid impurity 1 is a chemical impurity associated with Tranexamic acid, a synthetic derivative of lysine that inhibits fibrinolysis through the blockade of plasminogen activation. This compound serves as a critical reference standard for quality control and analytical validation in pharmaceutical development. Its characterization is essential for ensuring the purity and safety of Tranexamic acid formulations used in various medical applications. -
Drug Impurity
Baroxavir impurity 17 is a known impurity of Baroxavir, a drug primarily targeting viral RNA polymerases. This compound serves as an important reference standard in analytical chemistry, facilitating the assessment of purity and quality in Baroxavir formulations. Its characterization is crucial for ensuring compliance with regulatory standards in pharmaceutical research and development. -
Drug Impurity
Lopinavir impurity 7 is a characterized impurity of the antiviral compound Lopinavir, which primarily targets the HIV protease enzyme. This impurity is significant for analytical studies and quality control in pharmaceutical research, ensuring the integrity and safety of Lopinavir formulations. Its presence can influence the pharmacokinetic and pharmacodynamic properties of the parent compound, making it a valuable reference for investigators focused on drug development and formulation optimization. -
Drug Impurity
Fulvestrant impurity 1, also known as Fulvestrant 9-sulfone, is a known impurity of the selective estrogen receptor downregulator fulvestrant. It serves as a useful reference compound in the analysis of drug purity and stability in pharmaceutical formulations. This reagent is applicable in quality control and characterization studies within drug development and regulatory compliance. -
Drug Impurity
Esomeprazole impurity 2 is a known impurity associated with Esomeprazole, which is commonly used as a proton pump inhibitor. This compound is valuable for analytical and quality control purposes in pharmaceutical research, facilitating the assessment of drug purity and stability. Its identification and characterization are essential for ensuring compliance with regulatory standards in drug development and manufacturing. -
Drug Impurity
Aripiprazole impurity 35 is a known impurity associated with the antipsychotic drug Aripiprazole. This compound is primarily studied for its potential effects on the pharmacokinetics and safety profile of the parent drug. Researchers utilize this impurity in analytical studies to assess the purity of Aripiprazole formulations and to understand the implications of drug impurities on therapeutic efficacy and patient safety. -
Drug Impurity
tert-Butyl (6-(4-hydroxyphenoxy)hexyl) carbonate is identified as a drug impurity associated with pharmaceutical formulations. This compound is significant for its potential effects on drug stability and efficacy, making it relevant for quality control and analytical chemistry applications in drug development. Researchers may utilize this reagent to evaluate impurities in synthetic processes or assess compliance with regulatory standards. -
Cefazolin Impurity
Cefazolin Impurity H is a byproduct generated in the synthesis of Cefazolin, a semi-synthetic cephalosporin antibiotic. This impurity can be used as a reference standard in analytical chemistry for the identification and quantification of Cefazolin in pharmaceuticals. It is essential for ensuring the quality and efficacy of cefazolin formulations in research and development. -
Drug Impurity
Prasugrel chloride impurity maleate is a known impurity of Prasugrel chloride maleate, primarily used in pharmaceutical research and quality control applications. Its presence is critical for understanding the purity levels and potential implications for drug safety and efficacy. This compound enables the assessment of drug formulations to ensure compliance with regulatory standards in the development of antiplatelet therapies. -
Drug Impurity
Haloperidol impurity 18 is a known impurity associated with the antipsychotic drug Haloperidol. This compound is relevant for quality control and analytical research applications, as it aids in assessing the purity of Haloperidol formulations. It is essential for researchers investigating drug metabolism and safety profiles, contributing to a better understanding of pharmaceutical quality standards. -
Drug Impurity
Buspirone impurity 11 is a characterized impurity of the anxiolytic agent buspirone. It serves as a key reference standard for quality control and safety assessment in pharmaceutical formulations containing buspirone. This compound is essential for understanding the implications of drug impurities on therapeutic efficacy and patient safety during drug development and regulatory compliance. -
Drug Impurity
Bumetanide impurity 5 is a characterized impurity associated with the diuretic agent Bumetanide. This compound is important for analytical and quality control studies related to the synthesis and purity assessment of Bumetanide. It is utilized in pharmacokinetic research and drug formulation development to ensure compliance with regulatory standards for pharmaceutical products. -
Drug Intermediate Control
(rac)-Dihydrophytol is a versatile intermediate involved in the biosynthesis of Phytanic acid. It is utilized in research applications focused on the metabolic pathways of branched-chain fatty acids. This compound serves as a valuable tool in studies investigating lipid metabolism and related disorders. -
Drug Impurity
Sitagliptin impurity 9 phosphate is a known impurity associated with Sitagliptin phosphate. This compound serves as an important reference standard for the assessment of drug purity and quality control in pharmaceutical formulations. Its presence is critical for the evaluation of Sitagliptin's safety and efficacy in therapeutic applications, particularly in the management of Type 2 diabetes. -
Drug Intermediate
3-((1-Carboxy-2-((5,5-dimethyl-4,5-dihydroisoxazol-3-yl)thio)ethyl)amino)-3-oxopropanoic acid serves as a crucial organic synthetic intermediate in chemical research. Its molecular structure is designed to facilitate the synthesis of novel compounds with potential therapeutic applications. This reagent is particularly useful in the development of pharmacologically active molecules, contributing to advancements in medicinal chemistry. -
Drug Impurity
Tacrolimus impurity 9 is a known impurity of the immunosuppressant Tacrolimus, primarily affecting its chemical profile. This compound serves as a critical reference standard for analytical methods in the identification and quantification of Tacrolimus-related impurities. Its study is essential for ensuring the quality and safety of Tacrolimus formulations in pharmaceutical research and development. -
Drug Impurity
Citalopram impurity 11 is a known impurity associated with the selective serotonin reuptake inhibitor citalopram. Its presence is relevant in the analysis of pharmaceutical formulations and can serve as a reference standard in purity assessments. This compound is important for ensuring the quality control of citalopram and may facilitate studies on drug metabolism and safety profiles. -
Drug Impurity
Avibactam impurity 53 is a chemical impurity associated with the synthesis of Avibactam, a beta-lactamase inhibitor. This compound is relevant for analytical studies and quality control in drug development and formulation. It assists researchers in understanding and characterizing the purity profile of Avibactam-related compounds, facilitating compliance with regulatory standards in pharmaceutical research. -
Drug Impurity
Ropinirole impurity 2 is a chemical impurity associated with the synthesis of Ropinirole, a dopamine receptor agonist. This compound can be utilized for analytical purposes in the assessment of drug purity and quality control in pharmaceutical research. Its presence is significant for the evaluation of Ropinirole formulations and may impact the overall efficacy and safety profile of the drug. -
Drug Impurity
Tenofovir impurity 8 is a known impurity of Tenofovir, a nucleotide reverse transcriptase inhibitor. This compound may be used for quality control and characterization in pharmaceutical research to ensure the purity and safety of Tenofovir formulations. Its presence is critical for understanding the chemical profile and potential impacts on therapeutic efficacy and safety.
